Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.75B |
| 2 |
Walmart Inc
WMT
|
+$3.98B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.42B |
| 4 |
Broadcom
AVGO
|
+$943M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$785M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$572M |
| 2 |
NVIDIA
NVDA
|
+$566M |
| 3 |
Apple
AAPL
|
+$554M |
| 4 |
AbbVie
ABBV
|
+$455M |
| 5 |
Bank of America
BAC
|
+$411M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.24% |
| 2 | Technology | 9.52% |
| 3 | Healthcare | 7.46% |
| 4 | Financials | 6.74% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4301
PUT
Ares Management
ARES
$32.1B
| $1.12M | ﹤0.01% |
6,900
-700
| -9% | -$109K |
|
4302
Inseego
INSG
$72.3M
| $1.11M | ﹤0.01% |
+108,513
| New | +$1.41M |
|
4303
Interface
TILE
$2.23B
| $1.11M | ﹤0.01% |
39,859
-95,121
| -70% | -$2.59M |
|
4304
Kamada
KMDA
$478M
| $1.11M | ﹤0.01% |
157,610
-71,124
| -31% | -$492K |
|
|
RAC.U
4305
Rithm Acquisition Corp Units
RAC.U
| $1.11M | ﹤0.01% |
103,095
| – | – |
|
4306
Archer Daniels Midland
ADM
$39.3B
| $1.11M | ﹤0.01% |
19,238
-133,613
| -87% | -$7.98M |
|
4307
PACS Group
PACS
$6.77B
| $1.11M | ﹤0.01% |
28,796
-177,859
| -86% | -$3.9M |
|
|
FLOC
4308
Flowco Holdings
FLOC
$930M
| $1.1M | ﹤0.01% |
58,809
-207,266
| -78% | -$3.46M |
|
4309
CALL
Huntington Bancshares
HBAN
$34.2B
| $1.1M | ﹤0.01% |
+63,500
| New | +$1.04M |
|
4310
CTS Corp
CTS
$1.62B
| $1.1M | ﹤0.01% |
25,661
-60,573
| -70% | -$2.54M |
|
4311
CALL
Sempra
SRE
$55.1B
| $1.09M | ﹤0.01% |
12,400
-57,900
| -82% | -$5.27M |
|
|
GGN
4312
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$881M
| $1.09M | ﹤0.01% |
+212,098
| New | +$1.07M |
|
|
PDT
4313
John Hancock Premium Dividend Fund
PDT
$622M
| $1.09M | ﹤0.01% |
+86,098
| New | +$1.11M |
|
4314
Syndax Pharmaceuticals
SNDX
$1.74B
| $1.09M | ﹤0.01% |
51,937
-994,519
| -95% | -$17.3M |
|
4315
NB Bancorp
NBBK
$984M
| $1.09M | ﹤0.01% |
54,866
-488,416
| -90% | -$9.29M |
|
4316
Invesco China Technology ETF
CQQQ
$3.07B
| $1.09M | ﹤0.01% |
+20,900
| New | +$1.14M |
|
4317
PUT
Live Nation Entertainment
LYV
$42.3B
| $1.08M | ﹤0.01% |
+7,600
| New | +$1.09M |
|
|
JBS
4318
PUT
JBS N.V.
JBS
$44.7B
| $1.08M | ﹤0.01% |
75,000
-75,000
| -50% | -$1.03M |
|
|
QNRX
4319
Quoin Pharmaceuticals
QNRX
$12.3M
| $1.08M | ﹤0.01% |
+74,817
| New | +$1.02M |
|
4320
Park National Corp
PRK
$3.58B
| $1.08M | ﹤0.01% |
7,082
-2,153
| -23% | -$339K |
|
4321
BioCryst Pharmaceuticals
BCRX
$2.51B
| $1.07M | ﹤0.01% |
137,626
-323,321
| -70% | -$2.34M |
|
4322
CALL
Frontier Group Holdings
ULCC
$1.34B
| $1.07M | ﹤0.01% |
+227,800
| New | +$1.01M |
|
4323
ProFrac Holding
ACDC
$909M
| $1.07M | ﹤0.01% |
275,012
-42,434
| -13% | -$173K |
|
4324
Costamare
CMRE
$1.86B
| $1.07M | ﹤0.01% |
67,702
+49,721
| +277% | +$687K |
|
4325
PUT
Universal Health Services
UHS
$10.1B
| $1.07M | ﹤0.01% |
4,900
-3,700
| -43% | -$818K |
|
Similar funds
Israel Englander's Q4 2025 Portfolio in Review
As of Q4 2025, Israel Englander held 6,645 positions worth $238B, up 1.5% from $234B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Israel Englander's Q4 2025 filing shows 668 new, 2,203 increased, 2,701 reduced and 696 closed positions. Its largest new stake was iShares Russell 1000 ETF: 455,129 shares worth $170M. The largest sale was Microsoft, an estimated $572M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q4 2025 buy was iShares Russell 1000 ETF: 455,129 shares worth $170M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $4.75B increase.
- Israel Englander's biggest Q4 2025 reduction was Microsoft, cutting an estimated $572M.
- Israel Englander fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Israel Englander's ten largest holdings make up 19% of its $238B portfolio in Q4 2025.
- Israel Englander opened 668 new positions and closed 696 in Q4 2025.
- Israel Englander's portfolio value rose 1.5% quarter-over-quarter to $238B.
Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.